TABLE 2.
The prognostic effect of FN1 expression in breast cancer patients with restricted clinicopathological characteristics.
| Characteristics | Overall survival | Disease-free survival | ||
|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Grade | ||||
| Grade 1 | 0.61 (0.24-1.60) | 0.32 | 0.77 (0.44-1.34) | 0.35 |
| Grade 2 | 0.90 (0.60-1.33) | 0.59 | 0.87 (0.70-1.08) | 0.21 |
| Grade 3 | 1.51 (1.11-2.04) | 0.0081 | 1.52 (1.26-1.84) | 1.3e-5 |
| Subtype | ||||
| Luminal | 0.50 (0.23-1.06) | 0.064 | 1.39 (1.04-1.87) | 0.026 |
| HER2+ | 0.51 (0.14-1.80) | 0.28 | 1.79 (0.96-3.34) | 0.065 |
| Triple-negative | 2.40 (1.26-4.59) | 0.0063 | 1.27 (0.94-1.72) | 0.12 |
Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.